FGF23 and chronic kidney disease: In early CKD, despite phosphate overload, normophosphatemia is maintained by a compensatory increase in both circulating PTH and FGF-23 concentrations, which downregulate the expression of NaPi-2 cotransporters with phosphaturia effects [15].